What happened with BON today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Bon Natural Life Limited supplies ingredients that functional-food and personal-care businesses use in their products. Through Xi’an App-Chem, it sells fragrance compounds and food ingredients such as stachyose and apple polyphenol. These ingredient sales generate most of its revenue, with fragrance compounds the largest category. It produces in China and sells mainly through distributors there, with a smaller overseas business.
It also sells health-supplement powder drinks and helps smaller Chinese health-product businesses develop finished products, from formulation and ingredient procurement to manufacturing products for them. Customers pay for products supplied to agreed specifications, including ingredient purity.
Two customers supply a substantial share of revenue, while a small group of suppliers provides much of its purchased materials. The business therefore depends on retaining these customers and maintaining supplies for production. Its food operations require Chinese production and business licenses and compliance with food-safety and labeling rules. Its supplement products have not been approved by a Chinese regulator as effective treatments or preventives for disease.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Bon Natural Life Limited’s results hinge mainly on fragrance-compound and bioactive-ingredient prices, product mix and orders from a concentrated customer base—exposures these supplement peers reflect only partly.
Natural Alternatives International competes with Bon Natural Life Limited for supplement brands’ formulation and manufacturing work, including powdered nutritional products. Watch its revenue from making products sold under customers’ brands for a read on the business that overlaps with Bon’s functional-health services, rather than Bon’s fragrance ingredients.
USANA Health Sciences and Bon Natural Life Limited share exposure to Chinese consumers’ demand for nutritional supplements: USANA sells supplements to consumers and resellers, while Bon supplies domestic functional-health products and ingredients to business customers. USANA’s Chinese supplement business is the part to watch for that shared demand.
USANA Health Sciences Inc earningsUSNA
USANA’s report will show how demand for supplements among Chinese consumers is changing, offering a read on the market behind Bon Natural Life’s domestic functional-health business, which serves business customers.
Watch how USANA’s China supplement business performs. Stronger demand would suggest a more supportive market for supplement suppliers and brands, including the market behind Bon Natural Life’s domestic functional-health products and ingredients. Weaker demand would signal a tougher backdrop, but USANA sells to consumers and resellers, so its results do not directly establish how Bon’s business customers are ordering.
Bon Natural Life Limited earningsThis company
Bon Natural Life’s report will show whether sales of its fragrance compounds, supplement powder drinks and bioactive food ingredients generate enough gross profit to cover operating expenses.
Read revenue, gross margin and operating expenses together. Gross margin is the share of sales left after product costs. If revenue rises, gross margin improves and gross profit covers operating expenses, the sales mix and pricing are producing stronger results. If revenue grows but margins stay weak, or gross profit still falls short of operating expenses, sales growth has not yet translated into stronger operations.
